Inside J&J’s secret plan to cap litigation payouts to cancer victims
By Mike Spector and Dan Levine NEW YORK (Reuters) -Johnson & Johnson created a plan last year to limit the financial bleeding from billions of dollars in jury awards to plaintiffs who alleged the